Rathbones Group PLC trimmed its position in Danaher Corporation (NYSE:DHR - Free Report) by 5.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 265,499 shares of the conglomerate's stock after selling 13,971 shares during the quarter. Rathbones Group PLC's holdings in Danaher were worth $60,778,000 as of its most recent filing with the Securities and Exchange Commission.
Several other large investors have also modified their holdings of DHR. Enterprise Financial Services Corp raised its holdings in Danaher by 1.4% in the 4th quarter. Enterprise Financial Services Corp now owns 3,219 shares of the conglomerate's stock worth $737,000 after acquiring an additional 46 shares during the period. Revolve Wealth Partners LLC boosted its holdings in Danaher by 2.6% during the fourth quarter. Revolve Wealth Partners LLC now owns 1,870 shares of the conglomerate's stock valued at $428,000 after acquiring an additional 47 shares during the period. Kestra Private Wealth Services LLC grew its position in shares of Danaher by 0.3% in the third quarter. Kestra Private Wealth Services LLC now owns 15,421 shares of the conglomerate's stock valued at $3,057,000 after purchasing an additional 48 shares during the last quarter. Norway Savings Bank increased its stake in shares of Danaher by 0.7% in the fourth quarter. Norway Savings Bank now owns 7,063 shares of the conglomerate's stock worth $1,617,000 after purchasing an additional 49 shares during the period. Finally, SOL Capital Management CO increased its stake in shares of Danaher by 2.8% in the third quarter. SOL Capital Management CO now owns 1,829 shares of the conglomerate's stock worth $363,000 after purchasing an additional 50 shares during the period. 79.05% of the stock is owned by institutional investors.
Danaher Trading Up 0.0%
Shares of Danaher stock opened at $191.18 on Monday. Danaher Corporation has a 52-week low of $171.00 and a 52-week high of $242.80. The firm has a market capitalization of $135.30 billion, a PE ratio of 37.93, a price-to-earnings-growth ratio of 2.59 and a beta of 0.95. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.87 and a quick ratio of 1.51. The company's fifty day moving average price is $204.49 and its two-hundred day moving average price is $214.63.
Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings data on Tuesday, January 27th. The conglomerate reported $2.23 EPS for the quarter, topping analysts' consensus estimates of $2.14 by $0.09. Danaher had a net margin of 14.71% and a return on equity of 10.81%. The company had revenue of $6.84 billion during the quarter, compared to the consensus estimate of $6.79 billion. During the same period last year, the firm earned $2.14 EPS. The firm's revenue for the quarter was up 4.6% compared to the same quarter last year. On average, analysts expect that Danaher Corporation will post 7.63 EPS for the current year.
Danaher Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, April 24th. Shareholders of record on Friday, March 27th will be paid a dividend of $0.40 per share. This is a positive change from Danaher's previous quarterly dividend of $0.32. This represents a $1.60 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date is Friday, March 27th. Danaher's dividend payout ratio is 31.75%.
Wall Street Analyst Weigh In
Several analysts recently weighed in on the company. JPMorgan Chase & Co. increased their target price on Danaher from $270.00 to $275.00 and gave the company an "overweight" rating in a research note on Thursday, January 29th. Robert W. Baird set a $251.00 price target on Danaher in a report on Thursday, January 29th. KeyCorp reissued an "overweight" rating on shares of Danaher in a research report on Thursday, January 29th. TD Cowen reaffirmed a "buy" rating on shares of Danaher in a research report on Wednesday, January 7th. Finally, Argus set a $265.00 target price on shares of Danaher in a research note on Wednesday, January 14th. Nineteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, Danaher has an average rating of "Moderate Buy" and a consensus price target of $253.55.
View Our Latest Report on Danaher
Insiders Place Their Bets
In other news, EVP Gregory M. Milosevich sold 1,320 shares of the company's stock in a transaction that occurred on Thursday, February 19th. The stock was sold at an average price of $208.01, for a total value of $274,573.20. Following the sale, the executive vice president directly owned 5,099 shares in the company, valued at approximately $1,060,642.99. This represents a 20.56% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Insiders own 11.10% of the company's stock.
Danaher Profile
(
Free Report)
Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Stories
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report